Sign Up to Receive Your Personalised Learning Resources
Start Learning
FDA approves Susvimo® for diabetic macular edema
4D Molecular Therapeutics announces positive interim results from SPECTRA trial for DME
Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease
CE/CME ACCREDITED
Highlights of ASCRS 2024: Spotlight on groundbreaking developments
3 Questions with Melinda Chang: touchOPHTHALMOLOGY Future Leader 2025
SOE 2025: A message from the President
Why is an early diagnosis of generalised myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD) important?
Sponsored content
Late-breaking abstracts from EURETINA 2024: Advances in retinal therapies
Clinical pearls from WCC IX: Strategies in therapeutic keratoplasty
Research highlights from AAO 2024
FDA approves Susvimo® for diabetic macular edema
4D Molecular Therapeutics announces positive interim results from SPECTRA trial for DME
Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease
CE/CME ACCREDITED
Highlights of ASCRS 2024: Spotlight on groundbreaking developments
3 Questions with Melinda Chang: touchOPHTHALMOLOGY Future Leader 2025
SOE 2025: A message from the President
Why is an early diagnosis of generalised myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD) important?
Sponsored content
Late-breaking abstracts from EURETINA 2024: Advances in retinal therapies
Clinical pearls from WCC IX: Strategies in therapeutic keratoplasty
Research highlights from AAO 2024
FDA approves Susvimo® for diabetic macular edema
4D Molecular Therapeutics announces positive interim results from SPECTRA trial for DME
Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease
CE/CME ACCREDITED
Highlights of ASCRS 2024: Spotlight on groundbreaking developments
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
3 Questions with Dr Jelena Potic: touchOPHTHALMOLOGY Future Leader 2025
View
Foreword: touchREVIEWS in Ophthalmology, Volume 18, Issue 1, 2024
View
Promising results from the NORSE EIGHT clinical trial on ONS-5010 for wet AMD
View
3 Questions with Dr Emilio Torres-Netto: touchOPHTHALMOLOGY Future Leader 2025
View
Why is an early diagnosis of generalised myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD) important?
View
3 Questions with Dr Laura Maubon: touchOPHTHALMOLOGY Future Leader 2025
View
Highlights of ASCRS 2024: Spotlight on groundbreaking developments
View
Machine Learning Models for the Diagnosis of Dry Eyes Using Real-World Clinical Data
View
SOE 2025: A message from the President
View
Greatest hits of 2024
View
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGY
Sign me up!